For the quarter ending 2025-09-30, LUCD made $1,211,000 in revenue. -$10,397,000 in net income. Net profit margin of -858.55%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Revenue | 1,211,000 | 1,163,000 | 828,000 | 1,099,000 |
| Provision for income taxes | - | 0 | - | 0 |
| Cost of revenue | 1,697,000 | 1,563,000 | 1,551,000 | 1,900,500 |
| Sales and marketing | 4,291,000 | 4,007,000 | 4,069,000 | 4,098,500 |
| General and administrative | 5,605,000 | 5,617,000 | 6,162,000 | 4,967,000 |
| Amortization of acquired intangible assets | 105,000 | 105,000 | 105,000 | 239,000 |
| Research and development | 1,272,000 | 1,255,000 | 1,428,000 | 1,477,000 |
| Total operating expenses | 12,970,000 | 12,547,000 | 13,315,000 | 12,682,000 |
| Operating loss | -11,759,000 | -11,384,000 | -12,487,000 | -11,583,000 |
| Interest income | 101,000 | 110,000 | 66,000 | 67,000 |
| Interest expense | 2,000 | 6,000 | 9,000 | 9,500 |
| Debt extinguishments loss - senior secured convertible note | - | 0 | - | -2,109,500 |
| Change in fair value - senior secured convertible note | -2,341,000 | -6,841,000 | 14,478,000 | -2,558,500 |
| Equity issuance cost extinguishment | 1,078,000 | - | - | - |
| Other income (expense), net | 1,362,000 | 6,945,000 | -14,421,000 | 506,500 |
| Loss before provision for income tax | -10,397,000 | -4,439,000 | -26,908,000 | -11,076,500 |
| Net loss attributable to lucid diagnostics inc | -10,397,000 | -4,439,000 | -26,908,000 | -11,076,500 |
| Less series b and series b-1 convertible preferred stock dividends earned | - | 3,449,000 | 9,110,000 | - |
| Less deemed dividend on series a and series a-1 convertible preferred stock | - | 0 | - | 1,874,000 |
| Net loss attributable to lucid diagnostics inc. common stockholders | -10,397,000 | -7,888,000 | -36,018,000 | -14,824,500 |
| Net loss per share attributable to lucid diagnostics inc. common stockholders - basic | -0.1 | -0.08 | -0.52 | -0.285 |
| Net loss per share attributable to lucid diagnostics inc. common stockholders - diluted | -0.1 | -0.08 | -0.52 | -0.285 |
| Weighted average common shares outstanding, basic | 108,176,088 | 98,989,161 | 68,796,392 | -24,035,206.5 |
| Weighted average common shares outstanding, diluted | 108,176,088 | 98,989,161 | 68,796,392 | -24,035,206.5 |
Lucid Diagnostics Inc. (LUCD)
Lucid Diagnostics Inc. (LUCD)